TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...

That assessment was made by Shanghai-based Helen Chen, Greater China managing partner at L.E.K. Consulting, one of the most respected analysts in the mainland’s life sciences industry. “There is ...

Patients enrolled on the Children's Oncology Group neuroblastoma biology study ANBL00B1 (ClinicalTrials.gov identifier: NCT00904241) who received care at the University of Chicago (UChicago) or the ...

Cassie is a former deputy editor who collaborated with teams around the world while living in the beautiful hills of Kentucky. Focusing on bringing growth to small businesses, she is passionate about ...

Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma ASCO Guidelines provide recommendations ...

QuantHealth, an Israeli AI-enabled clinical trial-design startup, announced that David Dornstreich is joining the company as its general manager and chief commercial officer of U.S. operations, which ...

Mohsen Baqery is a Guide Staff Writer from Turkey. With a passion for gaming that borders on obsession, Mohsen thrives on guiding fellow gamers through the most challenging obstacles while exploring ...

Allscripts Healthcare Solutions completed the sale of its hospital and large physician practices business, including various electronic health record products. 1. Chicago-based Allscripts announced in ...

MADISON, Wis.--(BUSINESS WIRE)--Moxe Health (Moxe) announced today that Allscripts has certified Moxe Digital ROI as part of the Allscripts Developer Program. Moxe’s API-enabled solution allows ...

Allscripts announced on Wednesday that it had entered into an agreement with Toronto-based Constellation Software's N. Harris Computer Corporation to acquire the net assets of the electronic health ...